Modes of Hypotensive Action of Dihydroquercetin in Arterial Hypertension
- Autores: Plotnikov M.B.1, Aliev O.I.1, Sidekhmenova A.V.1, Shamanaev A.Y.1, Anishchenko A.M.1, Nosarev A.V.2, Pushkina E.A.2
- 
							Afiliações: 
							- Laboratory of Circulation Pharmacology, E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine
- Department of Biophysics and Functional Diagnostics, Siberian State Medical University
 
- Edição: Volume 162, Nº 3 (2017)
- Páginas: 353-356
- Seção: Article
- URL: https://journals.rcsi.science/0007-4888/article/view/238199
- DOI: https://doi.org/10.1007/s10517-017-3614-4
- ID: 238199
Citar
Resumo
We studied the effect of dihydroquercetin (20 mg/kg/day intragastrically for 6 weeks) on mean BP and macro- and microrheological blood parameters in hypertensive SHR rats; in vitro effect of dihydroquercetin on the tone in thoracic aorta rings isolated from hypertensive SHR rats were also examined. At the end of the treatment course, the mean BP in the experimental rats decreased by 11%; the left ventricular mass index by 2%, and whole blood viscosity by 7-10% in comparison with control SHR rats; erythrocyte aggregation half-time increased by 15%; plasma viscosity, hematocrit, and erythrocyte deformability did not change. In in vitro experiments, dihydroquercetin (10—8-10—6M) induced relaxation of the isolated thoracic aorta rings in a dose-dependent manner. Hence, the antihypertensive effect of dihydroquercetin results from the decrease in blood viscosity and vasodilation.
Sobre autores
M. Plotnikov
Laboratory of Circulation Pharmacology, E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine
							Autor responsável pela correspondência
							Email: mbp2001@mail.ru
				                					                																			                												                	Rússia, 							Tomsk						
O. Aliev
Laboratory of Circulation Pharmacology, E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine
														Email: mbp2001@mail.ru
				                					                																			                												                	Rússia, 							Tomsk						
A. Sidekhmenova
Laboratory of Circulation Pharmacology, E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine
														Email: mbp2001@mail.ru
				                					                																			                												                	Rússia, 							Tomsk						
A. Shamanaev
Laboratory of Circulation Pharmacology, E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine
														Email: mbp2001@mail.ru
				                					                																			                												                	Rússia, 							Tomsk						
A. Anishchenko
Laboratory of Circulation Pharmacology, E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine
														Email: mbp2001@mail.ru
				                					                																			                												                	Rússia, 							Tomsk						
A. Nosarev
Department of Biophysics and Functional Diagnostics, Siberian State Medical University
														Email: mbp2001@mail.ru
				                					                																			                												                	Rússia, 							Tomsk						
E. Pushkina
Department of Biophysics and Functional Diagnostics, Siberian State Medical University
														Email: mbp2001@mail.ru
				                					                																			                												                	Rússia, 							Tomsk						
Arquivos suplementares
 
				
			 
						 
						 
						 
						 
					 
				 
  
  
  
  
  Enviar artigo por via de e-mail
			Enviar artigo por via de e-mail  Acesso aberto
		                                Acesso aberto Acesso está concedido
						Acesso está concedido Somente assinantes
		                                		                                        Somente assinantes
		                                					